secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2024-09-04T23:59:59+00:00
Accession:  0001048477-24-000136
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin enters $600M revolving credit facility maturing 2029, undrawn at closing
--------------------------------------------------------------------------------

- Entered $600M revolving credit facility with Citibank as administrative agent.
- Facility matures on August 28, 2029; no amounts drawn at closing.
- Interest: Term SOFR plus 112.5-175 bps or Base Rate plus 12.5-75 bps, based on leverage.
- Proceeds to finance working capital and general corporate purposes.
- Includes customary covenants restricting debt, liens, investments, and dividends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000104847724000136/0001048477-24-000136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000104847724000136/bmrn-20240828.htm
  HTML page:      https://secwatch.observer/filing/0001048477-24-000136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer